ArticleCureus2025
Effectiveness of Antibiotic Cement-Coated Rods in the Management of Chronic Post-traumatic Osteomyelitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Differential approach for the management of femoral post-traumatic combat-related osteomyelitis in the war in Ukraine: a clinical case series.International journal of emergency medicine · 2026Article
- Threaded Antibiotic-Coated Locking Nails in Osteomyelitis-Associated Long-Bone Non-Union: Short-Term Outcomes of a Prospective Cohort.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic post-traumatic osteomyelitis (CPTO) remains a challenging orthopedic condition characterized by persistent infection, bone destruction, and delayed healing.
objectiveThis study aimed to evaluate the short-term effectiveness of locally fabricated antibiotic cement-coated rods in infection control and bone healing among patients with CPTO of the femur and tibia. METHODOLOGY: This descriptive study was conducted at the Department of Orthopedics, Hayatabad Medical Complex, Peshawar, Pakistan, from September 9, 2022, to March 9, 2023. A total of 126 patients aged 18-60 years with CPTO were included using consecutive non-probability sampling. Patients with non-union, segmental bone defects, or Cierny-Mader type IV osteomyelitis were excluded. All patients underwent standardized surgical debridement followed by the insertion of antibiotic cement-coated intramedullary rods prepared intraoperatively with vancomycin (2 g) and gentamicin (0.5 g) per 40 g of cement. Postoperative antibiotics were adjusted according to intraoperative culture and sensitivity results. Clinical and radiological assessments were performed at three and six weeks and at three months. Data were analyzed using IBM SPSS Statistics software, version 24 (IBM Corp., Armonk, NY).
resultsOf 126 patients, 77 (61.11%) were male and 49 (38.89%) female, with a mean age of 40.07 ± 11.44 years. The femur was involved in 96 patients (76.19%), and the tibia in 30 patients (23.81%). Treatment was effective in 108 patients (85.71%), while 18 patients (14.29%) experienced persistence or recurrence of infection. Pain relief improved from 78 patients (61.90%) at three weeks to 110 (87.30%) at three months. Sinus discharge resolved in 112 patients (88.89%) at three months. Radiologically, callus formation increased from 52 patients (41.27%) at three weeks to 101 (80.16%) at three months, and the absence of sequestrum improved from 90 (71.43%) to 113 (89.68%).
conclusionAntibiotic cement-coated rods demonstrate high short-term effectiveness in infection control and bone healing in CPTO. However, further multicenter studies with longer follow-up and standardized microbiological reporting are warranted to confirm long-term efficacy and reproducibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.